In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply
Denneman, L.; Cohen, S.; Godfried, M.H.; van Leeuwen, E.; Nellen, J.F.; Kuijpers, T.W.; Pajkrt, D.; van de Plas, A.; Smit, C.; Weijsenfeld, A.M.; Scherpbier, H.J.; Bunders, M.J.
Aids 31(4): 596-598
2017
ISSN/ISBN: 0269-9370 PMID: 28118235 DOI: 10.1097/qad.0000000000001338Document Number: 642796
Document emailed within 0-6 h
Related Documents
Ngoma, M.S.; Hunter, J.A.; Harper, J.A.; Church, P.T.; Mumba, S.; Chandwe, M.; Côté, H.él.èn.C.F.; Albert, A.Y.K.; Smith, M.-L.; Selemani, C.; Sandstrom, P.A.; Bandenduck, L.; Ndlovu, U.; Khan, S.; Roa, L.; Silverman, M.S. 2014: Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding Aids 28(Suppl 3): S323-S330Ades, V.; Mwesigwa, J.; Natureeba, P.; Clark, T.D.; Plenty, A.; Charlebois, E.; Achan, J.; Kamya, M.R.; Havlir, D.V.; Cohan, D.; Ruel, T.D. 2013: Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda Journal of Tropical Pediatrics 59(6): 441-446
Collins, I.J.; Cairns, J.; Ngo-Giang-Huong, N.; Sirirungsi, W.; Leechanachai, P.; Le Coeur, S.; Samleerat, T.; Kamonpakorn, N.; Mekmullica, J.; Jourdain, G.; Lallemant, M. 2014: Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand Plos one 9(3): E91004
Feinstein, L.; Edmonds, A.; Okitolonda, V.; Cole, S.R.; Van Rie, A.; Chi, B.H.; Ndjibu, P.; Lusiama, J.; Chalachala, J.L.; Behets, F. 2015: Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is Associated with Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo Journal of Acquired Immune Deficiency Syndromes 69(3): E93-E99
Thakwalakwa, C.; Phiri, A.; Rollins, N.; Heikens, G.T.; Barnell, E.K.; Manary, M. 2014: Growth and HIV-free survival of HIV-exposed infants in Malawi: a randomized trial of two complementary feeding interventions in the context of maternal antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 66(2): 181-187
Baeten, J.M.; Donnell, D.; Mugo, N.R.; Ndase, P.; Thomas, K.K.; Campbell, J.D.; Wangisi, J.; Tappero, J.W.; Bukusi, E.A.; Cohen, C.R.; Katabira, E.; Ronald, A.; Tumwesigye, E.; Were, E.; Fife, K.H.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Kidoguchi, L.; Coombs, R.W.; Hendrix, C.; Marzinke, M.A.; Frenkel, L.; Haberer, J.E.; Bangsberg, D.; Celum, C. 2014: Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial Lancet. Infectious Diseases 14(11): 1055-1064
Miller, H.C.; Hassanein, K. 1971: Diagnosis of impaired fetal growth in newborn infants Pediatrics 48(4): 511-522
Goodson, J.L.; Finkbeiner, T.; Davis, N.L.; Lyimo, D.; Rwebembera, A.; Swartzendruber, A.L.; Wallace, A.S.; Kimambo, S.; Kimario, C.J.; Wiktor, S.Z.; Luman, E.T. 2013: Evaluation of using routine infant immunization visits to identify and follow-up HIV-exposed infants and their mothers in Tanzania Journal of Acquired Immune Deficiency Syndromes 63(1): E9
Shukla, R.; Bornschein, R.L.; Dietrich, K.N.; Buncher, C.R.; Berger, O.G.; Hammond, P.B.; Succop, P.A. 1989: Fetal and infant lead exposure: effects on growth in stature Pediatrics 84(4): 604-612
Trice, J.E.; Ambler, M. 1985: Multiple cerebral defects in an infant exposed in utero to anticonvulsants Archives of Pathology and Laboratory Medicine 109(6): 521-523
Garber, J.E. 1989: Long-term follow-up of children exposed in utero to antineoplastic agents Seminars in Oncology 16(5): 437-444
Lanier, A.P.; Noller, K.L.; Decker, D.G.; Elveback, L.R.; Kurland, L.T. 1974: Cancer and Stilbestrol. A Follow-Up of 1,719 Persons Exposed to Estrogens in Utero and Born 19431959 Obstetrical and Gynecological Survey 29(6): 407-408
Lanier, A.P.; Noller, K.L.; Decker, D.G.; Elveback, L.R.; Kurland, L.T. 1973: Cancer and stilbestrol. A follow-up of 1,719 persons exposed to estrogens in utero and born 1943-1959 Mayo Clinic Proceedings 48(11): 793-799
Pinto, N.; Koren, G. 2003: Research on maternal and fetal safety after exposure to antidepressants in utero American journal of obstetrics and gynecology 189(6): 1810-1; author reply 1811
Bae, W.H.; Wester, C.; Smeaton, L.M.; Shapiro, R.L.; Lockman, S.; Onyait, K.; Thior, I.; Essex, M. 2008: Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants Aids 22(13): 1633-1640
Polk, B. 2002: Tenofovir--a new option for combination therapy Medizinische Monatsschrift für Pharmazeuten 25(4): 140-141
Bender, M.A.; Kumarasamy, N.; Mayer, K.H.; Wang, B.; Walensky, R.P.; Flanigan, T.; Schackman, B.R.; Scott, C.A.; Lu, Z.; Freedberg, K.A. 2010: Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50(3): 416-425
Margot, N.A.; Miller, M.D. 2005: In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1 Antiviral Therapy 10(2): 343-348
Auzelle, M.P.; Mensire, A.; Lachassine, E.; Caldera, R.; Boccara, J.F.; Chavinie, J.; Badoual, J. 1987: In utero treatment of fetal tachycardias with a digitalis-beta blocker combination. Apropos of 2 cases Journal de Gynecologie Obstetrique et Biologie de la Reproduction 16(3): 383-391
Mauss, S.; Milinkovic, A.; Hoffmann, C.; Holm, S.; Berger, F.; Martínez, E.; Kuhlmann, B.; Gatell, J.é; Schmutz, G. 2005: Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine Aids 19(1): 101-102